Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,849,356 papers from all fields of science
Search
Sign In
Create Free Account
Penciclovir Sodium
Known as:
1,9-Dihydro-2-amino-9-(4-hydroxy-3-(hydroxymethyl)butyl)-6H-purin-6-one Monosodium Salt
, 9-(4-Hydroxy-3-(hydroxymethyl)butyl)guanine, Monosodium Salt
, penciclovir, monosodium salt
The sodium salt form of penciclovir, a synthetic acyclic guanine derivative with antiviral activity, mainly used to treat infections from herpes…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
penciclovir
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Preparation and Evaluation of Penciclovir Microemulsion
Zhai Guang-xi
2007
Corpus ID: 203925367
Objective To prepare penciclovir microemulsion and evaluate its quality. Methods The formula of penciclovir microemulsion was…
Expand
2006
2006
Determination of Penciclovir Sodiumby Nonaqueous Micro-titration
C. Hao
2006
Corpus ID: 101896157
2005
2005
Determination of Penciclovir Sodium by pH-Indicator Absorbance Ratio Method
L. Sheng
2005
Corpus ID: 100876869
In this paper, pH-indicator absorbance. ratio method was used in determination of penciclovir Sodium. The result was compared…
Expand
2005
2005
Determination of Penciclovir Sodium by High Performance Liquid Chromatography
Xue Ai
2005
Corpus ID: 101479850
HPLC method was used in determination of penciclovir sodium.Compared with conventional nonaqueous titration,this method is more…
Expand
2002
2002
CL1-SR39: A noninvasive molecular imaging model of prostate cancer suicide gene therapy using positron emission tomography.
A. Pantuck
,
F. Berger
,
+5 authors
A. Belldegrun
Journal of Urology
2002
Corpus ID: 11667615
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE